Özer, Hakan, et al. “Canakinumab For The Treatment of Amyloidosis Secondary to Lung Cancer: Amyloidosis and Canakinumab”. Journal of European Internal Medicine Professionals, vol. 1, no. 3, July 2023, doi:10.5281/zenodo.8134945.